Outcomes at mean 4.1 years | HRT | Placebo | Relative hazard (95% CI)‡ | NNH (CI) |
---|---|---|---|---|
†Abbreviations defined in glossary. | ||||
‡Relative hazard ratio calculated by using Cox-proportional hazards model with intention to treat analyses. | ||||
§NNH for deep venous thrombosis provided by author. | ||||
Venous thromboembolism | 2.5% | 0.9% | 2.7 (1.4 to 5.0) | 256 (157 to 692) |
Deep venous thrombosis | 1.8% | 0.7% | 2.8 (1.3 to 6.0) | 339 (198 to 1150)§ |
Pulmonary embolism | 0.8% | 0.3% | 2.8 (0.9 to 8.7) | Not significant |